Sign In
Buy DGX
$196.12
+2.45 (+1.27%)
At Close: Jun 04, 2026
Quest Diagnostics Q4 2021 Earnings Preview (NYSE:DGX)
07:52pm, Wednesday, 02'nd Feb 2022 Seeking Alpha
Quest Diagnostics (NYSE:DGX) is scheduled to announce Q4 earnings results on Thursday, February 3rd, before market open.The consensus EPS Estimate is $3.18 (-29.0% Y/Y) and the
Is a Surprise Coming for Quest Diagnostics (DGX) This Earnings Season?
04:19pm, Wednesday, 02'nd Feb 2022 Zacks Investment Research
Quest Diagnostics (DGX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
03:05pm, Wednesday, 02'nd Feb 2022 Benzinga
Upgrades
Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09 in the year-ago quarter. At
Is a Surprise Coming for Quest Diagnostics (DGX) This Earnings Season?
01:04pm, Wednesday, 02'nd Feb 2022
Quest Diagnostics (DGX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Encompass Health (EHC) Q4 Earnings Lag Estimates
11:45pm, Tuesday, 01'st Feb 2022 Zacks Investment Research
Encompass Health (EHC) delivered earnings and revenue surprises of -8.49% and 1.09%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
CDC data confirm boosters offer high level of protection against severe COVID, bolster case for unvaccinated to get their shots
01:35pm, Tuesday, 01'st Feb 2022 MarketWatch
The risk of developing severe COVID-19 for people who are fully vaccinated and have received a booster dose is close to zero, according to the latest data from the Centers for Disease Control and Prev
Quest Diagnostics And Walmart Team Up To See Home Tests
10:49pm, Monday, 31'st Jan 2022 The Street
Customers can order tests for COVID-19, heart health and many other issues, and get their results online.
Quest Diagnostics (DGX) COVID Test Sales Aid Amid Price Woe
04:43pm, Monday, 31'st Jan 2022 Zacks Investment Research
Quest Diagnostics' (DGX) base business continues to improve, signifying the ongoing recovery trend of the industry.
Quest Diagnostics-Walmart team up to provide tests online
02:36pm, Monday, 31'st Jan 2022 Seeking Alpha
Quest Diagnostics <> said it will offer consumer-initiated laboratory testing powered by QuestDirect in collaboration with Walmart <>.The new solution allows an individual to
Quest Diagnostics (DGX) COVID Test Sales Aid Amid Price Woe
01:06pm, Monday, 31'st Jan 2022
Quest Diagnostics' (DGX) base business continues to improve, signifying the ongoing recovery trend of the industry.
Quest to sell 50 tests directly to consumers through Walmart's website
07:33am, Monday, 31'st Jan 2022
Shares of Quest Diagnostics Inc. DGX, -0.17% gained 1.0% in premarket trading on Monday after it said it will sell 50 common laboratory tests to consumers on Walmart Inc.'s WMT, +1.24% website. Consum
Dividend Champion, Contender, And Challenger Highlights: Week Of January 30
06:49am, Sunday, 30'th Jan 2022 Seeking Alpha
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Quest Diagnostics cut at Deutsche Bank to Hold
05:03pm, Friday, 28'th Jan 2022 Seeking Alpha
Quest Diagnostics (DGX) was downgraded by Deutsche Bank to Hold from Buy with a price target of $129, down from $190.Deutsche Bank analyst Pito Chickering is concerned that core lab
Benzinga's Top Ratings Upgrades, Downgrades For January 28, 2022
03:17pm, Friday, 28'th Jan 2022 Benzinga
Upgrades
According to Citigroup, the prior rating for Tractor Supply Co (NASDAQ:TSCO) was changed from Neutral to Buy. For the fourth quarter, Tractor Supply had an EPS of $1.93, compared to year-ago
Quest Diagnostics (DGX) Expected to Beat Earnings Estimates: Should You Buy?
08:01pm, Thursday, 27'th Jan 2022 Zacks Investment Research
Quest Diagnostics (DGX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
